What is it about?
the pharmacodynamics of monoclonal antibody therapy are ill known. Their post-administration serum levels need to be known
Featured Image
Why is it important?
to avoid over-dosage of monoclonal antibodies lab tests to estimate the right dose in personalized protocols
Perspectives
I hope that readers are convinced, as much as I am, that the dosage of monoclonal antibodies for treatment of inflammatory/autoimmune diseases needs to be scrutinized. Dosage schemes elaborated in clinical trials can not be translated 1 to 1 for my next patient; postmarketing analysis of these preps is imperative
Professor Urs Ernest Nydegger
University of Bern
Read the Original
This page is a summary of: Medical laboratory in autoimmunity 2017, LaboratoriumsMedizin, August 2017, De Gruyter,
DOI: 10.1515/labmed-2017-0077.
You can read the full text:
Contributors
The following have contributed to this page
